BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234
100 results:

  • 1. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
    Aljabry MS
    J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integration of Genomic Sequencing Drives Therapeutic Targeting of pdgfra in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic lymphoma.
    Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
    Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type.
    Xu T; Li Y; Liu Y; Ning B; Wu H; Wei Y
    Ann Hematol; 2023 Dec; 102(12):3521-3532. PubMed ID: 37702822
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::pdgfra rearrangement: Successful imatinib treatment in two cases.
    Bellani V; Croci GA; Bucelli C; Maronese CA; Alberti S; Iurlo A; Cattaneo D
    J Dermatol; 2023 Oct; 50(10):1330-1334. PubMed ID: 37248740
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anaplastic lymphoma kinase expression in pdgfra-mutated gastrointestinal stromal tumors probably correlates with poor prognosis.
    Wu Y; Gao B; Xia Q; Zhu Y; Wang N; Chang X; Huang B; Luo D; Zhang J; Zhang P; Shi H; Fan J; Nie X
    World J Surg Oncol; 2023 Apr; 21(1):138. PubMed ID: 37120571
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell lymphoma Patients.
    Wang H; Lin Y; Li Z; Wu Y; Yang Z; Gao S; Lin F
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649512
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
    Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FIP1L1-pdgfra fusion gene in T-lymphoblastic lymphoma: A case report.
    Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review.
    Tesileanu CMS; Vallentgoed WR; French PJ; van den Bent MJ
    Eur J Cancer; 2022 Nov; 175():214-223. PubMed ID: 36152406
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon.
    Chu X; Xu Y; Li Y; Zhou Y; Chu L; Yang X; Ni J; Li Y; Guo T; Zheng Z; Zheng Q; Yao Q; Li Y; Zhou X; Zhu Z
    Lung Cancer; 2022 Jul; 169():22-30. PubMed ID: 35609408
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/pdgfra axis.
    Arribas AJ; Napoli S; Cascione L; Sartori G; Barnabei L; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone-Pittau R; Di Veroli A; Stathis A; Cruciani G; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
    Haematologica; 2022 Nov; 107(11):2685-2697. PubMed ID: 35484662
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
    Kim AS; Pozdnyakova O
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):643-651. PubMed ID: 35478091
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deconvolution of Adult T-Cell Leukemia/lymphoma With Single-Cell RNA-Seq Using Frozen Archived Skin Tissue Reveals New Subset of Cancer-Associated Fibroblast.
    Joo EH; Bae JH; Park J; Bang YJ; Han J; Gulati N; Kim JI; Park CG; Park WY; Kim HJ
    Front Immunol; 2022; 13():856363. PubMed ID: 35464471
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Novel USP25::pdgfra Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm.
    Dalland JC; Blackburn PR; Reichard KK; Johnson SH; Smadbeck JB; Vasmatzis G; Hoppman NL; Xu X; Greipp PT; Baughn LB; Peterson JF
    Lab Med; 2022 Sep; 53(5):e134-e138. PubMed ID: 35217871
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease.
    Petinati NA; Shipounova IN; Fastova EA; Magomedova AU; Kravchenko SK; Chelysheva EY; Shukhov OA; Turkina AG; Sats NV; Drize NI; Parovichnikova EN; Savchenko VG
    Bull Exp Biol Med; 2021 Aug; 171(4):553-558. PubMed ID: 34542753
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Myeloid/lymphoid neoplasms with FLT3 rearrangement.
    Tang G; Tam W; Short NJ; Bose P; Wu D; Hurwitz SN; Bagg A; Rogers HJ; Hsi ED; Quesada AE; Wang W; Miranda RN; Bueso-Ramos CE; Medeiros LJ; Nardi V; Hasserjian RP; Arber DA; Orazi A; Foucar K; Wang SA
    Mod Pathol; 2021 Sep; 34(9):1673-1685. PubMed ID: 33990705
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutations in ALK and TSC1 in a gastrointestinal stromal tumor: a case report.
    Song Q; Li G; Li Z; Ao S; Hou J; Lv G
    BMC Surg; 2021 Apr; 21(1):202. PubMed ID: 33879132
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pdgfra Immunohistochemistry Predicts pdgfra Mutations in Gastrointestinal Stromal Tumors.
    Papke DJ; Forgó E; Charville GW; Hornick JL
    Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.